Håkon Hov
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Multiple Myeloma Research and Treatments 9
-
- Ubiquitin and proteasome pathways 2
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Magne Børset (11 shared papers)Unn‐Merete Fagerli (6 shared papers)Anders Waage (11 shared papers)Anders Sundan (11 shared papers)Randi Utne Holt (5 shared papers)Torstein B. Rø (4 shared papers)Vadim Baykov (3 shared papers)Henrik Hjorth‐Hansen (2 shared papers)
- Journals
- Blood (3 papers)Scandinavian Journal of Medicine and Science in Sports (2 papers)European Journal Of Haematology (2 papers)Clinical Cancer Research (1 paper)Experimental Hematology (1 paper)
- Partner nations
- NorwayUnited StatesGermany
In The Last Decade
Håkon Hov
18 papers receiving 302 citations
Peers
Comparison fields: 5 of 58
- Hematology 102
- Hepatology 58
- Otorhinolaryngology 22
- Oncology 77
- Complementary and alternative medicine 21
Countries citing papers authored by Håkon Hov
This map shows the geographic impact of Håkon Hov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkon Hov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkon Hov more than expected).
Fields of papers citing papers by Håkon Hov
This network shows the impact of papers produced by Håkon Hov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkon Hov. The network helps show where Håkon Hov may publish in the future.
Co-authors
The 25 scholars most cited alongside Håkon Hov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 76 | |
| 2 | 2009 | 40 | |
| 3 | 2008 | 35 | |
| 4 | 2020 | 32 | |
| 5 | 2013 | 25 | |
| 6 | 2022 | 20 | |
| 7 | 2016 | 17 | |
| 8 | 2012 | 11 | |
| 9 | 2018 | 11 | |
| 10 | 2019 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2018 | 6 | |
| 13 | 2015 | 5 | |
| 14 | 2008 | 5 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2006 | 2 | |
| 18 | 2007 | 1 | |
| 19 | 2026 | 0 | |
| 20 | 2006 | 0 |
About Håkon Hov
Håkon Hov is a scholar working on Hematology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Complementary and alternative medicine and Orthopedics and Sports Medicine, having authored 20 papers that have together received 306 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Cardiovascular and exercise physiology (3 papers), Liver physiology and pathology (3 papers), Sports injuries and prevention (3 papers), Sports Performance and Training (3 papers), Ubiquitin and proteasome pathways (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Hematology (102 citations), Hepatology (58 citations), Otorhinolaryngology (22 citations), Oncology (77 citations) and Complementary and alternative medicine (21 citations). Håkon Hov has collaborated with scholars based in Norway, United States and Germany. Frequent co-authors include Magne Børset, Unn‐Merete Fagerli, Anders Waage, Anders Sundan, Randi Utne Holt, Torstein B. Rø, Vadim Baykov, Henrik Hjorth‐Hansen, James G. Christensen and Toril Holien. Their work appears in journals such as Blood, Scandinavian Journal of Medicine and Science in Sports, European Journal Of Haematology, Clinical Cancer Research and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.